MedPath

Methotrimeprazine

Generic Name
Methotrimeprazine
Brand Names
Nozinan
Drug Type
Small Molecule
Chemical Formula
C19H24N2OS
CAS Number
60-99-1
Unique Ingredient Identifier
9G0LAW7ATQ
Background

A phenothiazine with pharmacological activity similar to that of both chlorpromazine and promethazine. It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)

Indication

For the treatment of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.

Associated Conditions
Amnesia-Memory Loss, Anxiety, Bipolar Disorder (BD), Cancer Pain, Nausea and vomiting, Phantom Limb Pain (PLP), Postherpetic Neuralgia, Schizophrenia, Senile psychosis, Trigeminal Neuralgia (TN), Neurocostal neuralgia
Associated Therapies
Perioperative analgesia

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath